Statistics for Solid Biosciences (id:8363 SLDB)
Valuation metrics
Market cap
199.77M
Enterprise value
47.38M
Trailing P/E (ttm)
0.15
Forward P/E
-1.82
PEG ratio
-1.82
Price/Sales (ttm)
Price/Book (mrq)
1.17
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.43
Overview
Shares outstanding
39.95M
Float
19.17M
Shares short
1.48M
% Held by insiders
0.01%
% Held by institutions
0.90%
Average volume (10 days)
287.24K
Average volume (90 days)
Price summary
52-Week low
2.63
52-Week high
15.05
52-Week change
43.07%
Beta
1.93
50-Day moving average
6.54
200-Day moving average
8.49
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 28th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-35.33%
Return on equity
-65.79%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-109,917,000.00
Net income to common (ttm)
-102,436,000.00
Diluted EPS (ttm)
-3.04
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
171.12M
Total cash per share (mrq)
4.28
Total debt (mrq)
24.72M
Total Debt/Equity (mrq)
14.80
Current ratio (mrq)
785.40%
Book value per share (mrq)
4.29
Cash flow
Cash flow statement
-91,190,000.00
Levered free cash flow (LFCF)
-56,140,624.00